Uma candidatura completa num minuto
Currículo e carta de apresentação personalizados, prontos a enviar.
The Christie NHS Foundation Trust in Manchester invites applications for a senior leader to provide strategic leadership for radiotherapy research and development, with a focus on advanced and adaptive radiotherapy techniques.
You will lead a translational radiotherapy research portfolio, manage research staff and AHP clinical academics, secure research funding, and drive the integration of innovative radiotherapy research into clinical practice.
The post holder will provide strategic leadership for radiotherapy research and development within the Trust, with a particular focus on advanced and adaptive radiotherapy techniques.
The post holder will lead and develop a portfolio of translational radiotherapy research, manage research staff and Allied Health Professional (AHP) clinical academics, secure research funding, and drive the integration of innovative radiotherapy research into clinical practice.
A key component of the role is to provide radiotherapy research leadership and input into Trust research strategy through active participation in the Radiotherapy Steering Group (RTSG), the Radiotherapy Research Committee (RRC), working collaboratively with clinical, research and academic colleagues.
The post holder will lead AHP clinical academic development, supporting radiographers and other AHPs from to develop and deliver research that contributes to the Trust's strategic aims and the wider national research agenda.
Main duties of the job
The post holder will input into trust radiotherapy research strategy via the RTSG and provide radiotherapy input into the Trust AHP research strategy (via the appropriate governance groups).
They will also represent AHP and radiotherapy research interests through membership in strategic and executive committees within the Trust and externally at local, regional, national and international levels. Lead a portfolio of translational radiotherapy research that aligns with the clinical and research strategies of the Radiotherapy Department, R&I Division, Trust, and funding initiatives.
Provide mentorship and guidance to academic staff, including supervision of MSc, PhD and other research students and support junior researchers. Lead horizon scanning for emerging radiotherapy technologies and research opportunities, translating these into feasible project proposals and funding applications.
Build strategic partnerships with internal and external stakeholders, including academic institutions, industry partners, and national research networks.
Lead the AHP Doctoral Academy and support the professional development of clinical academic staff through training, education, and mentorship. Undertake academic activity to maintain an academic appointment within a relevant division at the University of Manchester at the level of senior lecturer or above.
The Christie is one of Europe's leading cancer centres, looking after more than 64,000 patients a year. We are based in Manchester and serve a population of 3.2 million across Greater Manchester & Cheshire, but as a national specialist around 25% patients are referred to us from other parts of the country.
We are the largest radiotherapy provider in the NHS with one in 20 treatments delivered at The Christie. We have up to 15 linear accelerators operating across our network of sites. We operate the largest chemotherapy unit in the UK on our main site and treatments are also provided at 13 other networked sites, and in patients homes. And as a specialist tertiary surgical centre, we focus on rare cancers, complex procedures, and multidisciplinary approaches to cancer surgery, specialising in colorectal, peritoneal, gynaecological, urological and plastic surgery.
We are also an international leader in research, with world first breakthroughs for over 100 years. We have been named by the UK's National Institute for Health Research (NIHR), as one of the best hospitals providing opportunities for patients to participate in clinical research studies, with more than 800 studies open at any time, caring for over 3,000 patients.